Benzaldehyde → (S)-2-(Benzylamino)pentanedioic acid
反応式
O=C1N([CH2:7][C:8]2[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=2)[C@H](CC=O)CC1.[NH2:17][C@H:18]([C:24]([OH:26])=[O:25])[CH2:19][CH2:20][C:21]([OH:23])=[O:22].C(=O)C1C=CC=CC=1.[BH4-].[Na+]>>[C:8]1([CH2:7][NH:17][C@H:18]([C:24]([OH:26])=[O:25])[CH2:19][CH2:20][C:21]([OH:23])=[O:22])[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=1参加物
5
実験手順
The process set forth in Scheme I comprises the preparation of the intermediate, (S)-5-oxo-1-(phenylmethyl)-2-pyrrolidineacetaldehyde (10a). Thus, L-glutamic acid (3) can be reductively alkylated with benzaldehyde and sodium borohydride to yield the N-(1-phenylmethyl)-L-glutamic acid (4a). Acidification of the solution with hydrochloric acid to pH 3, followed by heating at reflux and then esterification of the crude product with methanol and sulfuric acid in toluene gives the (S)-5-oxo-1-(phenylmethyl)-2-pyrrolidinecarboxylic acid methyl ester (5). Reduction of (5) with sodium borohydride in methanol and t-butanol gives the hydroxymethyl compound characterized by formula (6). The optical purity of (S)-5-(hydroxymethyl)-1-(phenylmethyl)-2-pyrrolidinone (6), can be established by formation of the ester derived from (S)-(-)-α-methoxy-α-(trifluoromethyl)phenylacetic acid ((-)-MTPA) following the procedure of Mosher, et al. [J. Org. Chem. 1969, 34, 2543]. Conversion of (6) to the tosylate (7) was accomplished by treatment with p-toluenesulfonyl chloride and 4-dimethylaminopyridine. Treatment of the tosylate (7) with sodium iodide in acetone at reflux gives the iodide (8). Coupling of (8) with vinylmagnesium chloride, catalyzed by dilithium tetrachlorocuprate, leads to the propenyl compound (9), which can be ozonized in methanol with a methyl sulfide workup to yield the aldehyde, (S)-5-oxo-1-(phenylmethyl)-2-pyrrolidineacetaldehyde (10a). All of the steps described in Scheme I can be carried out using DL-glutamic acid or D-glutamic acid as the starting material, if it is desired to prepare enantiomeric or racemic (10a). ##STR19##